Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q2
$371K Buy
3,135
+944
+43% +$109K ﹤0.01% 1310
2026
Q1
$262K Buy
2,191
+187
+9% +$24.5K ﹤0.01% 1378
2025
Q4
$273K Buy
2,004
+408
+26% +$58.7K ﹤0.01% 1255
2025
Q3
$235K Buy
+1,596
New +$221K ﹤0.01% 1139

Other funds holding XYL

Waverly Advisors's XYL Position: Q2 2026 in Review

Waverly Advisors increased its Xylem (XYL) stake by 43% in Q2 2026, buying an estimated $109K and bringing the position to 3,135 shares worth $371K. The position accounts for ﹤0.01% of the portfolio, ranked #1310.

Waverly Advisors first reported a position in XYL in Q3 2025 and has held it in 4 quarters since. 1,103 funds tracked by Wall St. Rank hold XYL as of Q2 2026.

  • Waverly Advisors held 3,135 shares of Xylem worth $371K as of Q2 2026.
  • Waverly Advisors bought 944 Xylem shares in Q2 2026, an estimated $109K.
  • Xylem made up ﹤0.01% of Waverly Advisors's portfolio in Q2 2026, its #1310 holding.
  • Waverly Advisors first reported a position in Xylem in Q3 2025 and has held it in 4 quarters since.
  • 1,103 funds tracked by Wall St. Rank held Xylem as of Q2 2026.

Based on Waverly Advisors's 13F filing for Q2 2026, filed 14 Aug 2026.